ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.

Anne-Sophie Hamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.